Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19810592 | 0.95 | TSHR (0.58) | TSHRTDP1ALDH1A1 | |
| SCHEMBL1723918 | 0.90 | TSHR (0.64) | TSHRTDP1ALDH1A1 | |
| SCHEMBL1684315 | 0.86 | TSHR (0.58) | TSHRTDP1ALDH1A1 | |
| SCHEMBL2811713 | 0.86 | TSHR (0.58) | TSHRTDP1ALDH1A1 | |
| SCHEMBL7026060 | 0.79 | TSHR (0.41) | TSHRTDP1 | |
| SCHEMBL31458331 | 0.79 | — | — | |
| SCHEMBL14861 | 0.78 | TDP1 (1.00) | TSHRTDP1ALDH1A1 | |
| SCHEMBL28236221 | 0.78 | TDP1 (1.00) | TSHRTDP1ALDH1A1 | |
| SCHEMBL10000828 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL25381110 | 0.74 | TSHR (0.89) | TSHRTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112457164-B | Method for synthesizing parithenol | 南方科技大学 | 2023-01-03 | — | — | CN | claimed |
| CN-109071786-B | Two part curable composition | 汉高知识产权控股有限责任公司 | 2021-09-14 | — | — | CN | claimed |
| CN-112457164-A | Method for synthesizing parithenol | 南方科技大学 | 2021-03-09 | — | — | CN | claimed |
| CN-112457164-B | Method for synthesizing parithenol | 南方科技大学 | 2023-01-03 | — | — | CN | disclosed |
| CN-110475783-B | Cationic ruthenium complex, preparation method and application thereof | 高砂香料工业株式会社 | 2022-10-21 | — | — | CN | disclosed |
| CN-112457164-A | Method for synthesizing parithenol | 南方科技大学 | 2021-03-09 | — | — | CN | disclosed |
| CN-110950797-A | Preparation method of 2-trifluoromethyl-3-fluoro-4-picolinic acid and derivatives thereof | 丽水绿氟科技有限公司 | 2020-04-03 | — | — | CN | disclosed |
| US-9776999-B2 | Antiparisitic dihydroazole compounds and compositions comprising same | MERIAL INC. (US) | 2017-10-03 | — | — | US | disclosed |
| US-20170022197-A1 | ANTIPARISITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME | MERIAL, INC. (US) | 2017-01-26 | — | — | US | disclosed |
| US-9376434-B2 | Antiparisitic dihydroazole compounds and compositions comprising same | MERIAL INC. (US) | 2016-06-28 | — | — | US | disclosed |
| US-20160120839-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE | CELLIX BIO PRIVATE LIMITED (IN) | 2016-05-05 | — | — | US | disclosed |
| WO-2001049309-A2 | COMBINATIONS OF GROWTH FACTORS AND I: UPA OR I: MMP FOR THE TREATMENT OF DAMAGED TISSUE | PFIZER LIMITED (GB) | 2001-07-12 | — | — | WO | disclosed |
| WO-2000074681-A1 | METALLOPROTEASE INHIBITORS | PFIZER LIMITED (GB) | 2000-12-14 | — | — | WO | disclosed |
| EP-0685497-B1 | Stereospecific catalyst system for polymerisation of olefins | BOREALIS AS (DK) | 1999-11-03 | — | — | EP | disclosed |
| US-5869418-A | COMPOSED OF A TITANIUM COMPOUND, AN ORGANOALUMINUM COCATALYST AND A FIRST AND SECOND EXTERNAL ELECTRON DONOR, WHEREIN FIRST ELECTRON DONOR IS AN ACETAL DERIVATIVE OF AN ALDEHYDE | BOREALIS HOLDING A/S (DK) | 1999-02-09 | — | — | US | disclosed |
| WO-1995032994-A1 | STEREOSPECIFIC CATALYST SYSTEM FOR POLYMERIZATION OF OLEFINS | BOREALIS HOLDING A/S (DK) | 1995-12-07 | — | — | WO | disclosed |
| EP-0685497-A1 | Stereospecific catalyst system for polymerisation of olefins | Borealis Holding A/S (DK) | 1995-12-06 | — | — | EP | disclosed |
| WO-1994011788-A1 | METHOD OF PRODUCING MICROSTRUCTURES | TECHNISCHE UNIVERSITEIT DELFT (NL) | 1994-05-26 | — | — | WO | disclosed |
| CN-1067241-A | The method of terminal olefin oxidation system aldehyde | UNION CARBIDE CHEM PLASTIC (US) | 1992-12-23 | — | — | CN | disclosed |
| EP-0506068-A1 | Oxidation of terminal olefins to aldehydes | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1992-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170022197-A1 | ANTIPARISITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME | DDT, CYP1A1, CYP1A2 | TSHR 3439/4885TDP1 2384/4885ALDH1A1 74/4885 |
| US-20160120839-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE | ALPI, SLC10A2, SI | TSHR 2803/4885TDP1 4188/4885ALDH1A1 934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.